Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Myeloid 1Genitourinary 1

Conditions

Myelodysplastic Syndromes 1Multiple Myeloma 1

Interventions

fludarabine 32Specimen Handling 30Cyclophosphamide 28Azacitidine 28venetoclax 27Biopsy 24fludarabine phosphate 23ruxolitinib 18Whole-Body Irradiation 18Cytarabine 18Busulfan 18Mycophenolic Acid 17Tacrolimus 16asciminib 15Melphalan 14Injections 13Decitabine 13decitabine and cedazuridine drug combination 11X-Rays 11Stem Cell Transplantation 11Magnetic Resonance Spectroscopy 11Granulocyte Colony-Stimulating Factor 11Sirolimus 10Peripheral Blood Stem Cell Transplantation 10Cyclosporine 10Thiotepa 9Filgrastim 8nilotinib 7Methotrexate 7Imatinib Mesylate 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Home Care Services × Myeloid × 90 days × Clear all
NCT05969860 2026-04-20

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Mayo Clinic

Phase 2 Recruiting
220 enrolled
MyeloidPlasma cell

Multiple Myeloma, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡